Dear OSUCCC – James Faculty and Staff,
It is with great pleasure that I announce the appointments of two of our distinguished cancer researchers to top leadership positions at the OSUCCC. Gustavo Leone, PhD, is now our associate director for basic research, and Michael Lairmore, DVM, PhD, is our associate director for Shared Resources.
As associate director for basic research, Dr. Leone will oversee the efforts of some 275 investigators representing 11 colleges at The Ohio State University who are engaged in basic laboratory studies leading to discoveries that can be translated to innovative methods of detecting, treating and preventing cancer. He will also work to recruit additional senior faculty and physician scientists to expand Ohio State’s basic and translational research efforts in breast, genitourinary, gastrointestinal and thoracic cancer.
Dr. Leone’s lab studies the role of molecular pathways in coordinating cell growth and death signals in hopes of learning how these fundamental processes are coordinated during the cell cycle to regulate normal proliferation, the disruption of which often leads to cancer.
Dr. Leone also chairs a review committee for the Pelotonia Fellowship Program, which uses revenue generated by the annual Pelotonia bicycle tour fundraiser to provide cancer research opportunities for postdoctoral, graduate and undergraduate students at Ohio State.
As associate director for Shared Resources, Dr. Lairmore will oversee a network of 16 specialized services, or core facilities, that help investigators conduct cancer research by reaching across medical disciplines to offer expert leadership and training; clinical, administrative and technical support; and state-of-the-art instrumentation. Three new Shared Resources will open in 2011, including Medicinal Chemistry, Nutrient & Phytochemical, and Solid Tumor Correlative Science. Our Shared Resources are funded by the OSUCCC Support Grant from the National Cancer Institute, by partnerships with University colleges and departments, and by established chargeback systems.
Dr. Lairmore, who also serves as associate dean for research and graduate studies in Ohio State’s College of Veterinary Medicine, is an expert in molecular virology and veterinary pathology. He has a special interest in the biology of cancer-causing viruses such as HTLV-1, a retrovirus that can lead to adult T-cell leukemia and lymphoma. Earlier this year,
Dr. Lairmore was inducted into the national Institute of Medicine, one of the highest honors awarded to scientists in the biomedical fields.
Please join me in congratulating Drs. Leone and Lairmore on their new roles in helping us create a cancer-free world.
Michael A. Caligiuri, MD
Director, Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute
JL Marakas Nationwide Insurance Enterprise Foundation Chair of Cancer Research
The Ohio State University